Organic anion transporter 1B1: An important factor in hepatic thyroid hormone and estrogen transport and metabolism

Endocrinology

Volumn 149, Issue 9, 2008, Pages 4695-4701

  Van Der Deure, Wendy M ^a   Friesema, Edith C H ^a   De Jong, Frank Jan ^a   De Rijke, Yolanda B ^a   De Jong, Frank H ^a   Uitterlinden, André G ^a   Breteler, Monique M B ^a   Peeters, Robin P ^a   Visser, Theo J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BROMSULFOPHTHALEIN; ESTROGEN; ESTRONE SULFATE; IODOTHYRONINE; ORGANIC ANION TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 1B1; SULFATASE; THYROID HORMONE; THYROXINE DEIODINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BILIRUBIN BLOOD LEVEL; BILIRUBIN METABOLISM; CELL STRAIN COS1; CONTROLLED STUDY; ESTROGEN METABOLISM; GENETIC POLYMORPHISM; GENOTYPE; HORMONE METABOLISM; HUMAN; HUMAN CELL; LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SULFATION; THYROID HORMONE METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BILIRUBIN; BIOLOGICAL TRANSPORT; CERCOPITHECUS AETHIOPS; COS CELLS; ESTROGENS; ESTRONE; FEMALE; HUMANS; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; SULFATES; SULFOBROMOPHTHALEIN; THYROID HORMONES; THYROXINE;

EID: 50449105617     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-0169     Document Type: Article

References (35)

1. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME 2006 Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 90:5-22
2. Kester MH, van Dijk CH, Tibboel D, Hood AM, Rose NJ, Meinl W, Pabel U, Glatt H, Falany CN, Coughtrie MW, Visser TJ 1999 Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab 84:2577-2580
3. Kester MH, Kaptein E, Roest TJ, van Dijk CH, Tibboel D, Meinl W, Glatt H, Coughtrie MW, Visser TJ 1999 Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab 84:1357-1364
4. Wang J, Falany JL, Falany CN 1998 Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol Pharmacol 53:274-282
5. Li X, Clemens DL, Anderson RJ 2000 Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1). Biochem Pharmacol 60:1713-1716
6. 4S radioimmunoassay. Thyroid 2:101-105
7. Chopra IJ, Santini F, Hurd RE, Chua Teco GN 1993 A radioimmunoassay for measurement of thyroxine sulfate. J Clin Endocrinol Metab 76:145-150
8. Wu SY, Huang WS, Polk D, Chen WL, Reviczky A, Williams 3rd J, Chopra IJ, Fisher DA 1993 The development of a radioimmunoassay for reverse triiodothyronine sulfate in human serum and amniotic fluid. J Clin Endocrinol Metab 76:1625-1630
9. Chopra IJ, Wu SY, Teco GN, Santini F 1992 A radioimmunoassay for measurement of 3,5,3′-triiodothyronine sulfate: studies in thyroidal and nonthyroidal diseases, pregnancy, and neonatal life. J Clin Endocrinol Metab 75:189-194
10. Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ 2005 Alternate pathways of thyroid hormone metabolism. Thyroid 15:943-958
11. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89
12. Peeters RP, Kester MH, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2005 Increased thyroxine sulfate levels in critically ill patients as a result of a decreased hepatic type I deiodinase activity. J Clin Endocrinol Metab 90:6460-6465
13. Ruder HJ, Loriaux L, Lipsett MB 1972 Estrone sulfate: production rate and metabolism in man. J Clin Invest 51:1020-1033
14. Reed MJ, Purohit A, Woo LW, Newman SP, Potter BV 2005 Steroid sulfatase: molecular biology, regulation, and inhibition. Endocr Rev 26:171-202
15. Friesema EC, Docter R, Moerings EP, Stieger B, Hagenbuch B, Meier PJ, Krenning EP, Hennemann G, Visser TJ 1999 Identification of thyroid hormone transporters. Biochem Biophys Res Commun 254:497-501
16. Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, Nomura H, Unno M, Suzuki M, Naitoh T, Matsuno S, Yawo H 1999 Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 274:17159-17163
17. Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B 2001 Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology 120:525-533
18. Cui Y, Konig J, Leier I, Buchholz U, Keppler D 2001 Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 276:9626-9630
19. Tirona RG, Leake BF, Merino G, Kim RB 2001 Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European- and African-Americans. J Biol Chem 276:35669-35675
20. Konig J, Seithel A, Gradhand U, Fromm MF 2006 Pharmacogenomics of human OATP transporters. Naunyn Schmiedebergs Arch Pharmacol 372:432-443
21. Ieiri I, Suzuki H, Kimura M, Takane H, Nishizato Y, Irie S, Urae A, Kawabata K, Higuchi S, Otsubo K, Sugiyama Y 2004 Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects. Hepatol Res 30:91-95
22. Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its ratelimiting role in intracellular metabolism. Mol Endocrinol 20:2761-2772
23. Mol JA, Visser TJ 1985 Synthesis and some properties of sulfate esters and sulfamates of iodothyronines. Endocrinology 117:1-7
24. Vie MP, Evrard C, Osty J, Breton-Gilet A, Blanchet P, Pomerance M, Rouget P, Francon J, Blondeau JP 1997 Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. Mol Endocrinol 11:1728-1736
25. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG, Visser TJ 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-2888
26. Breteler MM 2000 Vascular involvement in cognitive decline and dementia. Epidemiologic evidence from the Rotterdam Study and the Rotterdam Scan Study. Ann NY Acad Sci 903:457-465
27. Visser TJ, Docter R, Hennemann G 1977 Radioimmunoassay of reverse triiodothyronine. J Endocrinol 73:395-396
28. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, Hofman A, van Leeuwen JP, Jehan F, Pols HA, Uitterlinden AG 2005 Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet 77:807-823
29. Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135
30. Visser TJ 1994 Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 92:293-303
31. Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Mol Endocrinol 22:1357-1369
32. Kameyama Y, Yamashita K, Kobayashi K, Hosokawa M, Chiba K 2005 Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 15:513-522
33. Cole MP, Jones CT, Todd ID 1971 A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474. Br J Cancer 25:270-275
34. Smith IE, Dowsett M 2003 Aromatase inhibitors in breast cancer. N Engl J Med 348:2431-2442
35. Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T 2003 Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol 86:455-460